| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68,801 |
55,921 |
$2.44M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,538 |
26,578 |
$1.47M |
| S9470 |
Nutritional counseling, dietitian visit |
17,434 |
17,025 |
$575K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,912 |
6,781 |
$544K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
14,967 |
13,678 |
$531K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,963 |
6,808 |
$510K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,783 |
5,647 |
$448K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
31,026 |
28,501 |
$374K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
33,417 |
15,838 |
$358K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,515 |
4,401 |
$334K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,610 |
9,490 |
$238K |
| 99000 |
|
14,615 |
13,192 |
$149K |
| 99429 |
|
5,129 |
5,077 |
$147K |
| 99050 |
|
9,185 |
8,403 |
$131K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12,975 |
9,978 |
$104K |
| 92552 |
|
6,826 |
6,719 |
$92K |
| 87420 |
|
8,469 |
7,674 |
$80K |
| 99381 |
|
994 |
975 |
$76K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,144 |
2,997 |
$74K |
| 87400 |
|
6,396 |
2,915 |
$72K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,567 |
2,312 |
$72K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,718 |
8,918 |
$55K |
| 99215 |
Prolong outpt/office vis |
613 |
558 |
$44K |
| 90461 |
|
6,636 |
5,400 |
$35K |
| H0049 |
Alcohol and/or drug screening |
3,615 |
3,589 |
$32K |
| 92567 |
|
2,266 |
2,174 |
$28K |
| 87428 |
|
443 |
431 |
$24K |
| 99051 |
|
3,444 |
3,239 |
$20K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,602 |
2,493 |
$19K |
| 87807 |
|
1,821 |
1,700 |
$18K |
| 83655 |
|
2,161 |
2,133 |
$17K |
| 17000 |
|
278 |
237 |
$13K |
| 92587 |
|
960 |
925 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
906 |
793 |
$10K |
| 0071A |
|
259 |
259 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
971 |
908 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
818 |
740 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
106 |
105 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
354 |
344 |
$8K |
| 0072A |
|
189 |
187 |
$7K |
| 99383 |
|
82 |
80 |
$7K |
| 82947 |
|
2,152 |
2,125 |
$6K |
| 99382 |
|
56 |
56 |
$5K |
| 81002 |
|
1,863 |
1,752 |
$5K |
| 96160 |
|
2,234 |
2,176 |
$3K |
| 90686 |
|
4,536 |
4,505 |
$3K |
| 80061 |
Lipid panel |
283 |
281 |
$3K |
| 85018 |
|
2,475 |
2,146 |
$2K |
| 99001 |
|
1,168 |
1,039 |
$2K |
| 84030 |
|
667 |
644 |
$1K |
| 0081A |
|
34 |
34 |
$1K |
| 86580 |
|
167 |
165 |
$1K |
| 0082A |
|
21 |
21 |
$840.00 |
| 0002A |
|
38 |
38 |
$840.00 |
| 94010 |
|
36 |
36 |
$795.41 |
| S8301 |
Infection control supplies, not otherwise specified |
93 |
93 |
$794.41 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$735.03 |
| 94016 |
|
35 |
35 |
$666.93 |
| CP002 |
|
68 |
63 |
$666.40 |
| 0001A |
|
27 |
27 |
$560.00 |
| 69210 |
|
26 |
26 |
$540.54 |
| 90480 |
|
18 |
18 |
$510.00 |
| 90619 |
|
579 |
564 |
$319.91 |
| 90677 |
|
934 |
909 |
$254.94 |
| 69209 |
|
25 |
25 |
$197.60 |
| 81025 |
|
27 |
25 |
$159.06 |
| 94760 |
|
155 |
138 |
$119.19 |
| 81003 |
|
19 |
17 |
$26.46 |
| 90656 |
|
1,095 |
1,084 |
$17.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
573 |
516 |
$13.98 |
| 90651 |
|
1,718 |
1,694 |
$0.81 |
| 90671 |
|
815 |
792 |
$0.78 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
2,211 |
2,151 |
$0.52 |
| 97802 |
|
3,699 |
3,586 |
$0.11 |
| 36416 |
|
1,945 |
1,856 |
$0.00 |
| 90723 |
|
2,716 |
2,679 |
$0.00 |
| 90680 |
|
2,845 |
2,800 |
$0.00 |
| 90696 |
|
945 |
928 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
7,938 |
7,781 |
$0.00 |
| 90716 |
|
353 |
349 |
$0.00 |
| 90647 |
|
3,673 |
3,629 |
$0.00 |
| 96127 |
|
4,120 |
4,081 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
44 |
44 |
$0.00 |
| 91307 |
|
500 |
461 |
$0.00 |
| 90698 |
|
337 |
330 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
121 |
116 |
$0.00 |
| 90657 |
|
52 |
52 |
$0.00 |
| 90697 |
|
99 |
95 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$0.00 |
| 82962 |
|
13 |
13 |
$0.00 |
| 99401 |
|
511 |
500 |
$0.00 |
| 90715 |
|
991 |
979 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,699 |
3,676 |
$0.00 |
| 90633 |
|
2,272 |
2,262 |
$0.00 |
| 90707 |
|
334 |
329 |
$0.00 |
| 90734 |
|
988 |
979 |
$0.00 |
| 90670 |
|
2,580 |
2,570 |
$0.00 |
| 91300 |
|
145 |
133 |
$0.00 |
| 90710 |
|
1,688 |
1,671 |
$0.00 |
| 99173 |
|
7,942 |
7,821 |
$0.00 |
| 90700 |
|
1,114 |
1,104 |
$0.00 |
| 90658 |
|
356 |
355 |
$0.00 |
| 91308 |
|
63 |
58 |
$0.00 |
| 91321 |
|
17 |
17 |
$0.00 |
| 90655 |
|
156 |
155 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
60 |
55 |
$0.00 |
| 99188 |
|
53 |
53 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
39 |
39 |
$0.00 |